• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症早期检测的生物标志物:分子方面。

Biomarkers for Early Detection of Cancer: Molecular Aspects.

机构信息

Asper Clinical Research Institute and Albrechtsen Research Centre, St. Boniface Hospital, Winnipeg, MB R2H 2A6, Canada.

Department of Pharmacology and Therapeutics, Rady Faculty of Health Sciences, Max Rady College of Medicine, University of Manitoba, Winnipeg, MB R3E 0T6, Canada.

出版信息

Int J Mol Sci. 2023 Mar 9;24(6):5272. doi: 10.3390/ijms24065272.

DOI:10.3390/ijms24065272
PMID:36982344
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10048948/
Abstract

According to the World Health Organization, cancer is a leading cause of death worldwide, representing almost 10 million deaths in 2020 [...].

摘要

世界卫生组织表示,癌症是全球主要死因之一,2020 年全球约有 1000 万人因此死亡[...]。

相似文献

1
Biomarkers for Early Detection of Cancer: Molecular Aspects.癌症早期检测的生物标志物:分子方面。
Int J Mol Sci. 2023 Mar 9;24(6):5272. doi: 10.3390/ijms24065272.
2
Mortality by cause for eight regions of the world: Global Burden of Disease Study.世界八个地区按病因划分的死亡率:全球疾病负担研究
Lancet. 1997 May 3;349(9061):1269-76. doi: 10.1016/S0140-6736(96)07493-4.
3
Developing world: Global warning.发展中世界:全球变暖。
Nature. 2014 May 29;509(7502):S64-5. doi: 10.1038/509S64a.
4
Understanding breast cancer as a global health concern.理解乳腺癌作为一个全球健康问题。
Br J Radiol. 2022 Feb 1;95(1130):20211033. doi: 10.1259/bjr.20211033. Epub 2021 Dec 14.
5
World cancer day: global action to avert 8 million cancer-related deaths by 2015.世界癌症日:到2015年避免800万癌症相关死亡的全球行动。
Indian J Med Sci. 2006 Feb;60(2):85-6.
6
MicroRNA-based Biosensors for Early Detection of Cancers.基于 microRNA 的癌症早期检测生物传感器。
Curr Pharm Des. 2018;24(39):4675-4680. doi: 10.2174/1381612825666190111144525.
7
Glycosylation-Based Serum Biomarkers for Cancer Diagnostics and Prognostics.用于癌症诊断和预后评估的基于糖基化的血清生物标志物
Biomed Res Int. 2015;2015:490531. doi: 10.1155/2015/490531. Epub 2015 Oct 5.
8
The changing face of cardiovascular disease 2000-2012: An analysis of the world health organisation global health estimates data.2000 - 2012年心血管疾病的变化面貌:对世界卫生组织全球卫生估计数据的分析
Int J Cardiol. 2016 Dec 1;224:256-264. doi: 10.1016/j.ijcard.2016.09.026. Epub 2016 Sep 15.
9
Stop cancer now!立即阻止癌症!
Lancet. 2013 Feb 9;381(9865):426-7. doi: 10.1016/S0140-6736(13)60060-4. Epub 2013 Feb 4.
10
Brave new world of cfDNA-omics for early cancer detection.用于早期癌症检测的cfDNA组学的全新世界。
J Immunother Cancer. 2023 Sep;11(9). doi: 10.1136/jitc-2022-006309.

引用本文的文献

1
In silico prediction of differentially expressed genes and functionally grouped networks in patients with inflamed pulp for screening pulpitis biomarkers.通过计算机模拟预测牙髓炎患者中差异表达基因及功能分组网络以筛选牙髓炎生物标志物。
Eur Oral Res. 2025 Jan 5;59(1):12-18. doi: 10.26650/eor.20241393951.
2
Exploring Selenoprotein P in Liver Cancer: Advanced Statistical Analysis and Machine Learning Approaches.探索肝癌中的硒蛋白P:高级统计分析和机器学习方法
Cancers (Basel). 2024 Jun 28;16(13):2382. doi: 10.3390/cancers16132382.
3
Emerging Targets and Therapeutics in Immuno-Oncology: Insights from Landscape Analysis.免疫肿瘤学中的新兴靶点与疗法:格局分析见解
J Med Chem. 2024 Jun 13;67(11):8519-8544. doi: 10.1021/acs.jmedchem.4c00568. Epub 2024 May 24.
4
Molecular methods in cancer diagnostics: a short review.癌症诊断中的分子方法:简短综述。
Ann Med. 2024 Dec;56(1):2353893. doi: 10.1080/07853890.2024.2353893. Epub 2024 May 16.
5
Biomarkers for Early Cancer Detection: A Landscape View of Recent Advancements, Spotlighting Pancreatic and Liver Cancers.早期癌症检测的生物标志物:近期进展全景,聚焦胰腺癌和肝癌
ACS Pharmacol Transl Sci. 2024 Feb 14;7(3):586-613. doi: 10.1021/acsptsci.3c00346. eCollection 2024 Mar 8.

本文引用的文献

1
Natural biomolecules and derivatives as anticancer immunomodulatory agents.天然生物分子及其衍生物作为抗癌免疫调节剂。
Front Immunol. 2023 Jan 9;13:1070367. doi: 10.3389/fimmu.2022.1070367. eCollection 2022.
2
Does COVID-19 Escalate Aging Process? A Possible Concern.新冠病毒会加速衰老进程吗?一个可能令人担忧的问题。
Adv Biomed Res. 2022 Nov 28;11:106. doi: 10.4103/abr.abr_350_21. eCollection 2022.
3
COVID-19 Mimics Pulmonary Dysfunction in Muscular Dystrophy as a Post-Acute Syndrome in Patients.COVID-19 在患者中作为一种急性后期综合征模拟了肌肉萎缩症的肺部功能障碍。
Int J Mol Sci. 2022 Dec 24;24(1):287. doi: 10.3390/ijms24010287.
4
Targeting the PI3K/AKT/mTOR Signaling Pathway in the Treatment of Human Diseases: Current Status, Trends, and Solutions.靶向PI3K/AKT/mTOR信号通路治疗人类疾病:现状、趋势与解决方案
J Med Chem. 2022 Dec 22;65(24):16033-16061. doi: 10.1021/acs.jmedchem.2c01070. Epub 2022 Dec 12.
5
Gemcitabine-Paclitaxel Chemotherapy for Patients with Advanced Urothelial Cancer Refractory to Cisplatin-Based Chemotherapy: Predictive Role of PGK1 for Treatment Response to Cytotoxic Chemotherapy.吉西他滨-紫杉醇化疗治疗顺铂化疗耐药的晚期尿路上皮癌患者:PGK1 对细胞毒化疗治疗反应的预测作用。
Int J Mol Sci. 2022 Oct 11;23(20):12119. doi: 10.3390/ijms232012119.
6
Molecular Biomarkers for the Early Detection of Ovarian Cancer.用于卵巢癌早期检测的分子生物标志物。
Int J Mol Sci. 2022 Oct 10;23(19):12041. doi: 10.3390/ijms231912041.
7
Current and future burden of breast cancer: Global statistics for 2020 and 2040.乳腺癌的现状和未来负担:2020 年和 2040 年全球统计数据。
Breast. 2022 Dec;66:15-23. doi: 10.1016/j.breast.2022.08.010. Epub 2022 Sep 2.
8
Downregulation of miR-99b-5p and Upregulation of Nuclear mTOR Cooperatively Promotes the Tumor Aggressiveness and Drug Resistance in African American Prostate Cancer.miR-99b-5p 下调和核 mTOR 上调协同促进非裔美国人前列腺癌的肿瘤侵袭性和耐药性。
Int J Mol Sci. 2022 Aug 25;23(17):9643. doi: 10.3390/ijms23179643.
9
Diagnostic Potential of Circulating Tumor Cells, Urinary MicroRNA, and Urinary Cell-Free DNA for Bladder Cancer: A Review.循环肿瘤细胞、尿液 microRNA 和尿液游离 DNA 对膀胱癌的诊断潜力:综述。
Int J Mol Sci. 2022 Aug 15;23(16):9148. doi: 10.3390/ijms23169148.
10
MicroRNA-99b-5p targets mTOR/AR axis, induces autophagy and inhibits prostate cancer cell proliferation.微小 RNA-99b-5p 靶向 mTOR/AR 轴,诱导自噬并抑制前列腺癌细胞增殖。
Tumour Biol. 2022;44(1):107-127. doi: 10.3233/TUB-211568.